Literature DB >> 33972455

Estimating the False-Positive Rate of Highly Automated SARS-CoV-2 Nucleic Acid Amplification Testing.

Christopher M Chandler1, Lori Bourassa1, Patrick C Mathias1,2, Alexander L Greninger1,3.   

Abstract

Entities:  

Keywords:  Hologic; Roche; SARS-CoV-2; false positive; high-throughput

Mesh：

Substances：

Year:  2021        PMID： 33972455      PMCID： PMC8288255          DOI： 10.1128/JCM.01080-21

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  4 in total

Review 1.  Validation of laboratory-developed molecular assays for infectious diseases.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Experience With False-Positive Test Results on the TaqPath Real-Time Reverse Transcription-Polymerase Chain Reaction Coronavirus Disease 2019 (COVID-19) Testing Platform.

Authors:  Leo Lin; John Carlquist; Will Sinclair; Tara Hall; Bert K Lopansri; Sterling T Bennett
Journal:  Arch Pathol Lab Med       Date:  2021-03-01       Impact factor: 5.534

3.  Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories.

Authors:  Joshua A Lieberman; Gregory Pepper; Samia N Naccache; Meei-Li Huang; Keith R Jerome; Alexander L Greninger
Journal:  J Clin Microbiol       Date:  2020-07-23       Impact factor: 5.948

4.  Two cases of novel coronavirus infection (COVID-19) with transient viral elevation using semi-quantitative real-time reverse transcription PCR and symptom relapse after completion of 10 days of favipiravir treatment.

Authors:  Hajime Tsuboi; Yu Kasamatsu; Shin Matsubara; Akifumi Sasao; Katsutomo Kunimitsu; Nana Munakata; Takamasa Ito; Yasuhiro Tsuchido; Masanaga Yamawaki; Naohisa Fujita
Journal:  J Infect Chemother       Date:  2020-12-23       Impact factor: 2.211
  4 in total
  4 in total

1.  SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center.

Authors:  Julia M Berger; Margaretha Gansterer; Wolfgang Trutschnig; Arne C Bathke; Robert Strassl; Wolfgang Lamm; Markus Raderer; Matthias Preusser; Anna S Berghoff
Journal:  Wien Klin Wochenschr       Date:  2021-08-19       Impact factor: 1.704

Review 2.  Rapid Antigen Assays for SARS-CoV-2: Promise and Peril.

Authors:  Thao T Truong; Jennifer Dien Bard; Susan M Butler-Wu
Journal:  Clin Lab Med       Date:  2022-03-04       Impact factor: 2.172

3.  Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario.

Authors:  Vincent Deslandes; Eric Clark; Venkatesh Thiruganasambandamoorthy; Marc Desjardins
Journal:  Diagn Microbiol Infect Dis       Date:  2021-11-27       Impact factor: 2.803

4.  Fast and noninvasive electronic nose for sniffing out COVID-19 based on exhaled breath-print recognition.

Authors:  Dian Kesumapramudya Nurputra; Ahmad Kusumaatmaja; Mohamad Saifudin Hakim; Shidiq Nur Hidayat; Trisna Julian; Budi Sumanto; Yodi Mahendradhata; Antonia Morita Iswari Saktiawati; Hutomo Suryo Wasisto; Kuwat Triyana
Journal:  NPJ Digit Med       Date:  2022-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.